PU-H71 is a potent Hsp90 inhibitor (IC50 = 50 nM); Hsp90 plays a critical role in modulating the activity of many cell signaling proteins and is an attractive target for anti-cancer therapeutics; studies indicate that Hsp90 inhibitors may serve as potential anti-Parkinson’s disease agents.